The Use of Novel Over-The-Scope-Clip to Prevent Esophageal Stent Migration
NOTSC-01
1 other identifier
interventional
108
0 countries
N/A
Brief Summary
New endoscopic clipping device called the over-the-scope-clip (OTSC) system (Ovesco Endoscopy, Tübingen, Germany) has become available for the closure of perforations, anastomotic leaks, and fistulas. The OTSC system has a stronger closing force than the through-the-scope hemostatic clip. Therefore, some researchers have reported esophageal SEMS fixation with an OTSC to prevent migration.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2023
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 29, 2023
CompletedStudy Start
First participant enrolled
June 1, 2023
CompletedFirst Posted
Study publicly available on registry
June 12, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2024
CompletedJune 12, 2023
June 1, 2023
7 months
January 29, 2023
June 2, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Esophageal SEMS migration rate at 4 weeks follow up.
Proportion of patients experiencing stent migration at 4 weeks after index procedure.
4 weeks
Secondary Outcomes (4)
Procedural time in minutes
immediately after procedure
Migration of stent in both groups
6 months
Adverse events in both groups apart from stent migration
6 months
Improvement in dysphagia score
1 week
Study Arms (2)
(Interventional) Patients undergoing Esophageal stenting with over the scope clip (OTSC) stent fix
EXPERIMENTALMarking clips will be placed with endoscopy at the upper end of the stricture. In mild stricture cases that allowed the passage of the endoscope, marking clips will also placed in the lower end. A stent that of at least 4 cm longer than the stricture will be used to allow at least a 2-cm extension above and below the proximal and distal tumor margins. The stent positioned over a guidewire and deployed under fluoroscopy guidance and, in some cases, also under endoscopy guidance. Subsequently, the OTSC system will be loaded onto the scope and part of the upper rim of the stent will be suctioned into the transparent cap before releasing the OTSC, grasping both the SEMS and esophageal wall. Investigator will avoid deploying the OTSC in areas of pulsations to prevent potential grasping of the vasculature structure. Only a single OTSC will be placed per participants.
(Non- Interventional) Participants undergoing Esophageal stenting without OTSC stent fix
NO INTERVENTIONThis will be the standard procedure of esophageal stent placement under fluro imaging/screening
Interventions
A stent that of at least 4 cm longer than the stricture will be used to allow at least a 2-cm extension above and below the proximal and distal tumor margins. The stent positioned over a guidewire and deployed under fluoroscopy guidance and, in some cases, also under endoscopy guidance. Subsequently, the OTSC system will be loaded onto the scope and part of the upper rim of the stent will be suctioned into the transparent cap before releasing the OTSC, grasping both the SEMS and esophageal wall. We will avoid deploying the OTSC in areas of pulsations to prevent potential grasping of the vasculature structure
Eligibility Criteria
You may qualify if:
- All adults (18+ years)
- Have benign, malignant non-stricture esophageal lesions (i.e. fistulae, perforation, leaks) warranting esophageal stent placement as an inpatient or outpatient
- Ability to consent to stent fixation.
You may not qualify if:
- Patients aged under 18 years of age
- Unable to provide informed consent
- Inherited or acquired coagulopathy likely to affect the risk of bleeding
- Receiving anticoagulant therapy that could not be stopped or bridged prior to procedure
- Breast feeding, pregnant and lactating women's.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Asian Institute of Gastroenterology, Indialead
- Ovesco Endoscopy AGcollaborator
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 29, 2023
First Posted
June 12, 2023
Study Start
June 1, 2023
Primary Completion
January 1, 2024
Study Completion
January 1, 2024
Last Updated
June 12, 2023
Record last verified: 2023-06